Kent Pharmaceuticals
Entry
2019
Hold
7yr
Status
Active
Who owns Kent Pharmaceuticals?
Kent Pharmaceuticals is currently owned by Duke Street through DS Cornerstone Fund (2017 vintage), since 2019.
Hand-verified · updated 2026-05-29
Most recent investor
Duke StreetDS Cornerstone Fund · 2017 · Buyout
2 ownership periods · full history below
Key facts
HQUK
SectorPharma
StatusActive
Ownership history
1 ownership period · 1 lender on file
Active
1 holder · 1 lender · 2019 · present
Duke StreetActive
2019 · present(7yr) · DS Cornerstone Fund · 2017 · Buyout
Apera Asset ManagementLender
2019 · present(7yr) · Apera Capital Private Debt Fund I · 2019 · Private Debt
More from DS Cornerstone Fund
Other portfolio companies in the same fund.
More PE-backed in Pharma
Comparable pharma deals from other GPs.
Track Kent Pharmaceuticals
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Kent Pharmaceuticals?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Kent Pharmaceuticals.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue